CG Oncology CGON Software and Technology Licenses, Net
Software and Technology Licenses, Net at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's software and technology licenses, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's software and technology licenses, net?
- CG Oncology (CGON) reported software and technology licenses, net of $2.68M in Q1 2026.
- How has CG Oncology's software and technology licenses, net changed year-over-year?
- CG Oncology's software and technology licenses, net increased by 418.6% year-over-year, from $516K to $2.68M.
- What is the long-term trend for CG Oncology's software and technology licenses, net?
- Over 2 years (2023 to 2025), CG Oncology's software and technology licenses, net has grown at a 839.8% compound annual growth rate (CAGR), from $19K to $1.68M.